These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3765052)

  • 21. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):127-32. PubMed ID: 2859157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional monitors of rejection in small intestinal transplants.
    Nordgren S; Cohen Z; Mackenzie R; Finkelstein D; Greenberg GR; Langer B
    Am J Surg; 1984 Jan; 147(1):152-8. PubMed ID: 6691542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN; Waltzer WC; Anaise D; Weinstein SW; Rapaport FT
    Transplantation; 1985 Dec; 40(6):605-10. PubMed ID: 3907030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous cyclosporine kinetics in renal failure.
    Follath F; Wenk M; Vozeh S; Thiel G; Brunner F; Loertscher R; Lemaire M; Nussbaumer K; Niederberger W; Wood A
    Clin Pharmacol Ther; 1983 Nov; 34(5):638-43. PubMed ID: 6627824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the immune system on cyclosporine absorption.
    Luke DR
    Xenobiotica; 1991 Jun; 21(6):817-24. PubMed ID: 1949911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM; Kasiske BL; Heim-Duthoy K; Rao KV
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cyclosporin A on allotransplanted pancreatic fragments to the spleen of totally pancreatectomized dogs.
    Du Toit DF; Reece-Smith H; McShane P; Denton T; Morris PJ
    Transplantation; 1982 Mar; 33(3):302-7. PubMed ID: 7039036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.
    Alexander DP; Horning L; Bowers LD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):499-508. PubMed ID: 3284097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine disposition in the dog..
    Buice RG
    Transplantation; 1986 Mar; 41(3):411-2. PubMed ID: 3952808
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of phenobarbital in dogs after multiple oral administration.
    Ravis WR; Nachreiner RF; Pedersoli WM; Houghton NS
    Am J Vet Res; 1984 Jul; 45(7):1283-6. PubMed ID: 24049884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
    D'mello A; Venkataramanan R; Satake M; Todo S; Takaya S; Ptachcinski RJ; Burckart GJ; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):441-54. PubMed ID: 2781141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, inhibition of lymphoblast transformation, and toxicity of cyclosporine in clinically normal pigs.
    Vaden SL; Riviere JE
    Am J Vet Res; 1990 Mar; 51(3):399-403. PubMed ID: 2316917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.
    Grevel J; Nüesch E; Abisch E; Kutz K
    Eur J Clin Pharmacol; 1986; 31(2):211-6. PubMed ID: 3803418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients.
    Flechner SM; Kolbeinsson ME; Tam J; Lum B
    Transplantation; 1989 May; 47(5):806-10. PubMed ID: 2655218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segmental pancreatic allograft survival in baboons treated with combined irradiation and cyclosporine: a preliminary report.
    du Toit DF; Heydenrych JJ; Smit B; Louw G; Zuurmond T; Laker L; Els D; Weideman A; Wolfe-Coote S; van der Merwe EA
    Surgery; 1985 Apr; 97(4):447-54. PubMed ID: 3885455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
    Venkataram S; Awni WM; Jordan K; Rahman YE
    J Pharm Sci; 1990 Mar; 79(3):216-9. PubMed ID: 2338629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.
    Lorber MI; Van Buren CT; Flechner SM; Williams C; Kahan BD
    Transplantation; 1987 Jan; 43(1):35-40. PubMed ID: 3541320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy.
    Kahan BD; Grevel J
    Transplantation; 1988 Nov; 46(5):631-44. PubMed ID: 3057685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.